Fund profile · Compiled from public sources

Ono Venture Investment

South San Francisco, United States · Seed → Series B

Their stated focus (public profile)

Ono Venture Investment, Inc. (OVI) is the corporate venture capital arm of Ono Pharma, an R&D-oriented pharmaceutical company. OVI invests in early-stage startups with innovative technologies and novel therapeutic drug targets in oncology, immunology & inflammation, and neurology. The fund prioritizes companies with high synergy to the R&D activities of its parent company, Ono Pharma.

Stages: Seed → Series B

Sectors: Life sciences, Inflammation

On file: 6 partners on record · 3 companies on record

Website: onoventure.com

This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.

Is this your fund? Request a correction or removal.

For founders · Find a fund

Search the funds we have on file

Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.

    Looking to claim your own fund? Start here →